Jacqueline Iris Lee, MD
General Surgery · Kailua
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Castle Medical Center · 77 clinicians in this group
Looking this up.
Hospitals listed: Adventist Health Castle. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lee’s office at (808) 263-5142 to ask if they take your plan before you enroll.
California Medical Board record
Licence A136691 · Current
Licensed to practise in California · since 2015 · expires 2027-06-30 · State University of New York at Stony Brook Health Sciences Center.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health CastleKailua, HIAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Castle
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 434 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.41 to 1.21) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 159.06 (98.05 to 220.07) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 11 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.6 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 234 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.6 · 130 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.41) · 2,414 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,445 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.51 (1.19 to 5.84) · 504 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 75 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (0.44 to 3.72) · 450 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.47 (0 to 16.56) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.82 (0.66 to 8.99) · 77 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 136 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.26 (0 to 1.12) · 1,792 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.492 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 149 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 246 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.8 · 114 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 18.2 · 135 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 4.4 · 241 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 14.8 · 359 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (3.8 to 9) · 70 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (6.9 to 14.5) · 70 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 74 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.2 (9 to 16.4) · 121 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (0.9 to 1.7) · 168 cases | No different | Jan 2024 – Dec 2024 |
What patients said (675 patients answered, 24% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 90% |
| "Always" quiet at night | 60% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
Original Medicare doctor bills
$36,399
Medicare paid this office $36,399 for 82 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $3,972 | $137 |
| Long return visit (40+ min) | 15 | $2,292 | $109 |
| New patient visit (45+ min) | 24 | $2,265 | $94 |
| Return visit (30+ min) | 17 | $1,702 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,624 | $62 |
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 1-10 | None |
| Hernia repair - groin (open) | 1-10 | None |
| Mastectomy | 15 | More than 72% of doctors who do this |
Who their Medicare patients are
82 Original Medicare patients in 2024. Average age 76 · Women 71% · Health risk score 1.29. At or below the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 74% · Cancer 39% · Diabetes 34% · Chronic kidney disease 28% · Coronary heart disease 24% · COPD 23% · Atrial fibrillation 16% · Heart failure 13%.
The office billed $114,656, Medicare allowed $46,107 and paid $36,399; for 209 services of 45 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 82 | 209 | 76 | 1.29 | $114,656 | $36,399 |
| 2023 | 76 | 196 | 75 | 1.62 | $125,064 | $38,347 |
| 2022 | 52 | 100 | 73 | 1.14 | $56,886 | $16,559 |
| 2021 | 41 | 93 | 72 | 2.73 | $60,913 | $18,580 |
| 2020 | 81 | 217 | 70 | 4.51 | $167,343 | $48,134 |
| 2019 | 110 | 241 | 70 | 3.30 | $167,363 | $43,742 |
| 2018 | 104 | 273 | 67 | 4.23 | $239,977 | $60,454 |
| 2017 | 77 | 177 | 62 | 4.36 | $158,004 | $32,876 |
| 2016 | 44 | 139 | 55 | 6.23 | $188,089 | $15,679 |
| 2015 | 34 | 79 | 53 | 8.03 | $103,280 | $9,399 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| New patient visit (45+ min) | 18 | $2,400 | $133 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $1,950 | $139 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,355 | $104 |
2022: 1 service
| New patient visit (15+ min) | 14 | $760 | $54 |
2021: 1 service
| Short return visit (20+ min) | 16 | $1,495 | $79 |
2020: 6 services
| Transplantation of donor kidney | 16 | $18,974 | $1,186 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $3,136 | $60 |
| New patient visit (45+ min) | 15 | $2,098 | $140 |
| Short return visit (20+ min) | 20 | $1,856 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,252 | $114 |
| Return visit (30+ min) | 11 | $1,120 | $93 |
2019: 5 services
| Transplantation of donor kidney | 12 | $8,617 | $718 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,964 | $165 |
| New patient visit (45+ min) | 21 | $2,700 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,339 | $48 |
| Short return visit (20+ min) | 21 | $1,328 | $58 |
2018: 6 services
| Transplantation of donor kidney | 21 | $20,671 | $984 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $5,017 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,710 | $159 |
| New patient visit (60+ min) | 11 | $1,834 | $167 |
| New patient visit (45+ min) | 13 | $1,691 | $130 |
| Emergency department visit with moderate level of medical decision making | 16 | $1,450 | $91 |
2017: 2 services
| Transplantation of donor kidney | 11 | $8,726 | $793 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,423 | $60 |
2016: 3 services
| Transplantation of donor kidney | 18 | $6,100 | $339 |
| Return visit (30+ min) | 13 | $2,111 | $68 |
| Preparation of donor kidney for transplantation | 13 | $165 | $13 |
2015: 3 services
| Transplantation of donor kidney | 15 | $5,100 | $340 |
| Return visit (30+ min) | 12 | $1,265 | $70 |
| Preparation of donor kidney for transplantation | 11 | $139 | $13 |
Medicaid work
$36 in 2021
Medicaid paid $36 for 25 billed services this clinician did in 2021, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 25 | $36 |
| 2021 | 25 | 1 | 12 | $36 |
Drugs they prescribed that Part D paid
$89
Pharmacies billed $89 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 65% of their Part D prescriptions (13 of 20) in 2024. Too few prescriptions to compare fairly with other clinicians.
19 generic and fewer than 11 brand-name prescriptions · $89 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone | 11 | $8 | $1 |
Year by year
| 2024 | 20 | 16 | 65% (13) | None | $89 |
| 2023 | 35 | 23 | 60% (21) | None | $512 |
| 2022 | 11 | None | None | None | $98 |
| 2021 | 49 | 20 | 33% (16) | None | $4,652 |
| 2020 | 61 | 15 | 21% (13) | None | $2,443 |
| 2019 | 90 | 31 | 26% (23) | 13% | $19,381 |
| 2018 | 144 | 32 | 19% (28) | None | $39,030 |
| 2017 | 52 | 21 | 37% (19) | None | $9,407 |
| 2016 | 33 | 15 | 52% (17) | None | $1,248 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Oxycodone | 13 | $31 | $2 |
2021: 1 drug
| Oxycodone-Acetaminophen | 14 | $59 | $4 |
2020: 2 drugs
| Oxycodone-Acetaminophen | 11 | $133 | $12 |
| Sulfamethoxazole-Trimethoprim | 13 | $82 | $6 |
2019: 3 drugs
| Valganciclovir | 11 | $12,222 | $1,111 |
| Oxycodone-Acetaminophen | 17 | $158 | $9 |
| Sulfamethoxazole-Trimethoprim | 11 | $53 | $5 |
2018: 4 drugs
| Valganciclovir | 27 | $32,873 | $1,218 |
| Oxycodone-Acetaminophen | 21 | $227 | $11 |
| Pantoprazole | 12 | $98 | $8 |
| Sulfamethoxazole-Trimethoprim | 16 | $50 | $3 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 14 | $170 | $12 |
Money from drug and device companies
$150 in 2025
| 2025 | 3 | 6 | None | $150 |
| 2024 | 3 | 4 | None | $72 |
| 2023 | 3 | 3 | None | $61 |
| 2022 | 3 | 3 | None | $51 |
| 2020 | 3 | 3 | None | $87 |
| 2019 | 5 | 25 | None | $3,962 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ethicon US | Harmonic | $110 | 4 payments
|
| Solventum | Prevena | $22 | 1 payment
|
| Novo Nordisk | None | $18 | 1 payment
|
See all 6 published payments
| Ethicon US | Meals · 2025-08-22 | Harmonic | $39 |
| Novo Nordisk | Meals · 2025-08-07 | None | $18 |
| Solventum | Meals · 2025-07-25 | Prevena | $22 |
| Ethicon US | Meals · 2025-06-26 | Harmonic | $15 |
| Ethicon US | Meals · 2025-06-25 | Surgiflo Hemostatic Matrix | $38 |
| Ethicon US | Meals · 2025-02-24 | Harmonic | $18 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $72
| Ethicon US | Echelon; Endopath | $42 | 2 payments
|
| Solventum | V.A.C. Dermatac | $15 | 1 payment
|
| Abbvie | Ubrelvy | $15 | 1 payment
|
2023: $61
| Genentech USA | None | $27 | 1 payment
|
| W. L. Gore & Associates | Gore Synecor Biomaterial | $18 | 1 payment
|
| Ethicon US | Echelon; Endopath | $16 | 1 payment
|
2022: $51
| W. L. Gore & Associates | Gore Bio-A Tissue Reinforcement | $21 | 1 payment
|
| Ethicon US | Echelon Endopath | $16 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Gattex | $14 | 1 payment
|
2020: $87
| Davol | Phasix | $52 | 1 payment
|
| Smith+Nephew | Grafix | $21 | 1 payment
|
| Zimmer Biomet Holdings | Surgical-None | $14 | 1 payment
|
2019: $3,962
| Medtronic USA | Plasmablade | $1,963 | 9 payments
|
| Medical Device Business Services | Echelon Flex Stapler | $1,855 | 9 payments
|
| Ethicon US | Surgicel Powder | $96 | 5 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $28 | 1 payment
|
| Veloxis Pharmaceuticals | Envarsus | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 72.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619137809
- Licence
- CA 136691California A136691: Current · expires 2027-06-30
- Trained
- State Un of Ny, Stony Brook School of Dental Med, 2008
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Surgery (208600000X)
- Mailing address
- Po Box 660599, Dallas, TX, 75266
- NPI first listed
- 2008-06-11
- NPI last updated
- 2015-06-17
This is when the NPI record was last certified, not a medical board exam.